CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,210 | $567.30 | $1.8M | 46,261 |
| 2026-05-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −4,407 | $568.00 | $2.5M | 41,854 |
| 2026-05-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,181 | $568.86 | $672K | 40,673 |
| 2026-05-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $569.73 | $91K | 40,513 |
| 2026-05-22 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 173,910 | ||
| 2026-05-21 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $117.76 | $1.2M | 28,876 |
| 2026-05-21 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −40 | $557.85 | $22K | 28,836 |
| 2026-05-21 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −320 | $560.03 | $179K | 28,516 |
| 2026-05-21 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −920 | $562.01 | $517K | 27,596 |
| 2026-05-21 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,677 | $563.12 | $1.5M | 24,919 |
| 2026-05-21 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,081 | $564.10 | $1.2M | 22,838 |
| 2026-05-21 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,765 | $565.10 | $997K | 21,073 |
| 2026-05-21 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,197 | $566.12 | $1.2M | 18,876 |
| 2026-05-21 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 70,000 | ||
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $557.85 | $22K | 49,973 |
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $560.03 | $157K | 49,693 |
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −919 | $561.97 | $516K | 48,774 |
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,760 | $562.98 | $991K | 47,014 |
| 2026-05-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,242 | $563.77 | $1.3M | 44,772 |
Page 97 of 120 · 2,391 trades